Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 8.01 Other Events.
On January 19, 2011, the Board of Directors of Enzon Pharmaceuticals,
Inc. (the “Company”) determined that the 2011 Annual Meeting of Stockholders (the “Annual Meeting”) will
be held on May 10, 2011, and that the record date for determining stockholders entitled to vote at the Annual Meeting is April
In accordance with Rule 14a-5(f) under the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), the Company has determined that proposals to be considered for inclusion
in the Company’s proxy statement for the Annual Meeting pursuant to Rule 14a-8 under the Exchange Act must be received by
the Company at its principal executive offices on or before February 10, 2011. In addition, in order for a stockholder proposal
made outside of Rule 14a-8 under the Exchange Act to be considered “timely” within the meaning of Rule 14a-4(c) of
the Exchange Act, such proposal must be received by the Company at its principal executive offices on or before February 7, 2011.
Proposals should be directed to the attention of the Corporate Secretary, Enzon Pharmaceuticals, Inc., 685 Route 202/206, Bridgewater,
New Jersey 08807.
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 25, 2011
||/s/ Andrew Rackear
|| Vice President and General Counsel